Logo
LUMIFIL KISS

LUMIFIL KISS

LUMIFIL

Dermal Fillers
  • CE Certified hyaluronic acid dermal filler (as part of the LUMIFIL dermal filler range).
  • Manufactured in accordance with applicable medical device and quality management standards (e.g. ISO Based quality systems) as declared by the manufacturer.
Hyaluronic acid lip and facial dermal filler

Description

LUMIFIL KISS (often listed as LUMIFIL L-KISS with Lidocaine) is a high-viscosity, cross-linked hyaluronic acid dermal filler specifically developed for lip augmentation and other facial areas requiring a thicker gel. Formulated with lidocaine for improved comfort, it delivers natural-looking volume and definition with high viscoelasticity and low phase angle, helping the product stay close to the injection site with minimal migration. KISS can be used in the lips as well as in the cheeks, chin, jawline and nasolabial folds, with results typically lasting around 9–12 months when injected by a qualified practitioner.

Bnefits

  • Ideal HA filler for lip augmentation and shaping with a fuller yet natural look.
  • High-viscosity, high-viscoelastic gel suitable for areas requiring more structure and volume.
  • Formulated for use in multiple facial areas including cheeks, chin, jawline and nasolabial folds (depending on wrinkle severity).
  • Contains lidocaine (0.3%) to reduce discomfort during injection.
  • High particle weight (around 2,500,000 kDa) for durable volumising effects.
  • Low phase angle helps the filler remain localised, reducing product migration.
  • Smooth, soft texture integrates well with surrounding tissues for natural contouring.
  • Long-lasting results, typically around 9–12 months, depending on area treated and individual factors.

Indications

  • Lip augmentation (volume, contour and definition).
  • Enhancement of the vermillion border and Cupid’s bow.
  • Correction of moderate to deep nasolabial folds (depending on clinical assessment).
  • Volume restoration and contouring of the cheeks.
  • Chin and jawline definition and contouring.
  • Smoothing of perioral wrinkles and fine lines around the mouth, where appropriate.

Composition

  • 20 mg/mL cross-linked hyaluronic acid (HA).
  • 3 mg/mL lidocaine (approximately 0.3%).
  • Phosphate-buffered saline (excipient solution).

Formulation

  • Cross-linked hyaluronic acid gel with lidocaine for injectable dermal filling.
  • High-viscosity, high-viscoelastic HA gel with particle weight around 2,500,000 kDa.
  • Sterile, pyrogen-free, single-use prefilled syringe intended for intradermal/submucosal injection by trained professionals.

Packaging

  • 1 x 1 mL prefilled sterile syringe of LUMIFIL KISS.
  • Typically supplied with disposable sterile needles (e.g. 27G–30G, needle size may vary by batch or distributor).
  • Packaged in a sealed box with product labelling, batch number and expiry date.

Usage

  • For professional use only; must be injected by appropriately trained and qualified medical or aesthetic practitioners.
  • Review patient medical history, including allergies (especially to hyaluronic acid, lidocaine or other local anaesthetics) and contraindications, and obtain informed consent before treatment.
  • Disinfect the treatment area thoroughly using appropriate antiseptic measures.
  • Select appropriate injection technique (e.g. linear threading, serial puncture, fanning) and depth (typically intradermal or submucosal/subcutaneous depending on area and indication).
  • Inject slowly using minimal pressure, checking tissue response frequently and avoiding overcorrection.
  • Gently mould the product after injection if required to achieve the desired contour and even distribution.
  • Do not inject into blood vessels; aspirate cautiously in line with current best practice to reduce risk of intravascular injection.
  • Advise patients to avoid makeup on treated areas for several hours after treatment and to minimise exposure to extreme heat, cold or intense sun for a short period post-procedure.
  • Inform patients about expected transient reactions (e.g. swelling, redness, tenderness) and provide clear instructions on when to seek urgent medical help (e.g. signs of vascular compromise or infection).

Contraindications

  • Known hypersensitivity to hyaluronic acid, lidocaine or other amide-type local anaesthetics, or to any excipient in the product.
  • History of severe allergic reactions or anaphylaxis.
  • Active skin infection, inflammation or disease (e.g. herpes, bacterial or fungal infection) at or near the intended injection site.
  • Autoimmune diseases or immunosuppressive therapy where injectable fillers are considered unsuitable by the treating clinician.
  • Tendency to develop hypertrophic scars or keloids, depending on clinical judgment.
  • Pregnancy or breastfeeding (generally contraindicated for elective aesthetic fillers).
  • Bleeding disorders or concurrent use of anticoagulant/antiplatelet therapy where the risk of bruising or haematoma is deemed unacceptable by the clinician.
  • Previous permanent fillers or complications in the same treatment area unless carefully evaluated by a specialist.

Adverse Effects

  • Common transient reactions such as redness, swelling, tenderness, itching, discolouration or bruising at the injection site.
  • Localised pain or discomfort during and shortly after injection (usually reduced by the presence of lidocaine).
  • Lumps, nodules or unevenness if product is placed superficially or not evenly distributed.
  • Delayed onset swelling or inflammatory reactions in rare cases.
  • Infection at the injection site if aseptic technique is not adequately maintained.
  • Very rare but serious risks associated with intravascular injection, including tissue ischaemia, necrosis, visual disturbance or blindness, which require immediate emergency management.

Storage Conditions

  • Store in the original packaging until use.
  • Keep at controlled room temperature as specified in the product leaflet (typically between 2°C and 25°C).
  • Do not freeze.
  • Protect from direct sunlight and excessive heat.
  • Keep out of the reach and sight of children.
  • Do not use after the expiry date or if the blister or syringe appears damaged or previously opened.

Duration

Clinical effects generally last approximately 9\u201312 months, depending on the treatment area, injection technique, patient metabolism and lifestyle factors. Repeat treatments may be performed as needed following professional assessment.

Onset

Volume and contour enhancement are usually visible immediately after injection, with optimal results apparent once initial swelling or redness subsides over several days.

Browse more Dermal Fillers

Top Treatments

Top Cities in the UK